Project description:ObjectivesThis study examines recently revised Korean government legislation addressing global infectious disease control for public health emergency situations, with the aim of proposing more rational, effective and realistic interpretations and applications for improvement of law.MethodsThe Korea reported its first laboratory-confirmed case of Middle East Respiratory Syndrome (MERS) coronavirus on May 20, 2015. Since the first indexed case, Korean public health authorities enforced many public health measures that were not authorized in the law; the scope of the current law was too limited to cover MERS. Korea has three levels of government: the central government, special self-governing provinces, and si/gun/gu. Unfortunately, the Infectious Disease Control and Prevention Act does not designate the specific roles of each level of government, and does not state how these governmental branches should be vertically integrated in a state of emergency.ResultsWhen thinking about these policy questions, we should be especially concerned about introducing a new act that deals with all matters relevant to emerging infectious diseases. The aim would be to develop a structure that specifies the roles of each level of government, and facilitates the close collaboration among them, then enacting this in law for the prevention and response of infectious disease.ConclusionsTo address this problem, after analyzing the national healthcare infrastructure along with the characteristics of emerging infectious diseases, we propose the revision of the relevant law(s) in terms of governance aspects, emergency medical countermeasure aspects, and the human rights aspect.
Project description:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has now become a serious global threat after inflicting more than 8 million infections and 425,000 deaths in less than 6 months. Currently, no definitive treatment or prevention therapy exists for COVID-19. The unprecedented rise of this pandemic has rapidly fueled research efforts to discover and develop new vaccines and treatment strategies against this novel coronavirus. While hundreds of vaccines/therapeutics are still in the preclinical or early stage of clinical development, a few of them have shown promising results in controlling the infection. Here, in this review, we discuss the promising vaccines and treatment options for COVID-19, their challenges, and potential alternative strategies.
Project description:A key component in controlling the spread of an epidemic is deciding where, when and to whom to apply an intervention. We develop a framework for using data to inform these decisions in realtime. We formalize a treatment allocation strategy as a sequence of functions, one per treatment period, that map up-to-date information on the spread of an infectious disease to a subset of locations where treatment should be allocated. An optimal allocation strategy optimizes some cumulative outcome, e.g. the number of uninfected locations, the geographic footprint of the disease or the cost of the epidemic. Estimation of an optimal allocation strategy for an emerging infectious disease is challenging because spatial proximity induces interference between locations, the number of possible allocations is exponential in the number of locations, and because disease dynamics and intervention effectiveness are unknown at out-break. We derive a Bayesian on-line estimator of the optimal allocation strategy that combines simulation-optimization with Thompson sampling. The estimator proposed performs favourably in simulation experiments. This work is motivated by and illustrated using data on the spread of white nose syndrome, which is a highly fatal infectious disease devastating bat populations in North America.
Project description:The oral cavity is a unique complex ecosystem colonized with huge numbers of microorganism species. Oral cavities are closely associated with oral health and sequentially with systemic health. Many factors might cause the shift of composition of oral microbiota, thus leading to the dysbiosis of oral micro-environment and oral infectious diseases. Local therapies and dental hygiene procedures are the main kinds of treatment. Currently, oral drug delivery systems (DDS) have drawn great attention, and are considered as important adjuvant therapy for oral infectious diseases. DDS are devices that could transport and release the therapeutic drugs or bioactive agents to a certain site and a certain rate in vivo. They could significantly increase the therapeutic effect and reduce the side effect compared with traditional medicine. In the review, emerging recent applications of DDS in the treatment for oral infectious diseases have been summarized, including dental caries, periodontitis, peri-implantitis and oral candidiasis. Furthermore, oral stimuli-responsive DDS, also known as "smart" DDS, have been reported recently, which could react to oral environment and provide more accurate drug delivery or release. In this article, oral smart DDS have also been reviewed. The limits have been discussed, and the research potential demonstrates good prospects.
Project description:Epidemiological models are powerful tools for evaluating scenarios and visualizing patterns of disease spread, especially when comparing intervention strategies. However, the technical skill required to synthesize and operate computational models frequently renders them beyond the command of the stakeholders who are most impacted by the results. Participatory modelling (PM) strives to restructure the power relationship between modellers and the stakeholders who rely on model insights by involving these stakeholders directly in model development and application; yet, a systematic literature review indicates little adoption of these techniques in epidemiology, especially plant epidemiology. We investigate the potential for PM to integrate stakeholder and researcher knowledge, using Phytophthora ramorum and the resulting sudden oak death disease as a case study. Recent introduction of a novel strain (European 1 or EU1) in southwestern Oregon has prompted significant concern and presents an opportunity for coordinated management to minimize regional pathogen impacts. Using a PM framework, we worked with local stakeholders to develop an interactive forecasting tool for evaluating landscape-scale control strategies. We find that model co-development has great potential to empower stakeholders in the design, development and application of epidemiological models for disease control. This article is part of the theme issue 'Modelling infectious disease outbreaks in humans, animals and plants: epidemic forecasting and control'. This theme issue is linked with the earlier issue 'Modelling infectious disease outbreaks in humans, animals and plants: approaches and important themes'.
Project description:The fundamental limitations of systemic therapeutic administration have prompted the development of local drug delivery platforms as a solution to increase effectiveness and reduce side effects. By confining therapeutics to the site of disease, local delivery technologies can enhance therapeutic index. This review highlights recent advances and opportunities in local drug delivery strategies for cancer treatment in addition to challenges that need to be addressed to facilitate clinical translation. The benefits of local cancer treatment combined with technological advancements and increased understanding of the tumor microenvironment, present a prime breakthrough opportunity for safer and more effective therapies.
Project description:BackgroundEmerging technologies and societal changes create new ethical concerns and greater need for cross-disciplinary and cross-stakeholder communication on navigating ethics in research. Scholarly articles are the primary mode of communication for researchers, however there are concerns regarding the expression of research ethics in these outputs. If not in these outputs, where should researchers and stakeholders learn about the ethical considerations of research?ObjectivesDrawing on a scoping review, analysis of policy in a specific disciplinary context (learning and technology), and reference group discussion, we address concerns regarding research ethics, in research involving emerging technologies through developing novel policy that aims to foster learning through the expression of ethical concepts in research.ApproachThis paper develops new editorial policy for expression of research ethics in scholarly outputs across disciplines. These guidelines, aimed at authors, reviewers, and editors, are underpinned by: a cross-disciplinary scoping review of existing policy and adherence to these policies;a review of emerging policies, and policies in a specific discipline (learning and technology); and,a collective drafting process undertaken by a reference group of journal editors (the authors of this paper).ResultsAnalysis arising from the scoping review indicates gaps in policy across a wide range of journals (54% have no statement regarding reporting of research ethics), and adherence (51% of papers reviewed did not refer to ethics considerations). Analysis of emerging and discipline-specific policies highlights gaps.ConclusionOur collective policy development process develops novel materials suitable for cross-disciplinary transfer, to address specific issues of research involving AI, and broader challenges of emerging technologies.
Project description:This cross-sectional, descriptive survey study aimed to identify the factors affecting emerging infectious disease prevention behaviors among young workers aged < 40 years. The factors affecting infection prevention behaviors among young workers were investigated with respect to perception of personal, inter-personal, organizational, and community responses based on ecological modeling. A total of 260 young workers residing in Jeollabuk-do region in South Korea were selected via convenience sampling. Multiple regression analysis performed to assess the factors affecting emerging infectious disease prevention behaviors. Multiple regression analysis revealed that infection prevention behaviors were significantly higher among healthy female participants compared with that in not very healthy female participants. Furthermore, infection prevention behaviors were significantly lower among those residing with family members with a confirmed diagnosis compare with that in those who did not. The infection prevention behaviors were higher among participants with higher levels of perceived susceptibility and perceived self-efficacy showed higher infection prevention behaviors. Thus, health managers should actively promote the implementation of infection prevention behaviors in the workplace by developing executable infection prevention guidelines and programs to enhance the perceived susceptibility and self-efficacy of workers in preparation for outbreaks of emerging infectious diseases.